Olimel N5e (Valine, Alanine, Arginine, Histidine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serin)

The blend delivers ten essential amino acids directly into the bloodstream, bypassing the gut. These amino acids serve as building blocks for protein synthesis, stimulate the mTOR pathway, replenish nitrogen pools, and support the production of enzymes and neurotransmitters, thereby helping maintain metabolic balance in patients receiving parenteral nutrition.

The prescribed dose of Olimel N5e is individualized by the treating physician based on the patient’s nutritional needs, body weight, renal and hepatic function, and the composition of the overall parenteral regimen. No standard dose is provided here; the prescriber determines the appropriate amount.

Safety data for Olimel N5e in pregnancy or lactation are limited. Because it is a nutritional supplement, it may be used when the potential benefit outweighs any risk, but the decision should be made by the prescribing clinician in consultation with obstetric care. No specific contraindication is listed.

Submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and the necessary import documentation.

Olimel N5e offers a balanced blend of ten essential amino acids in a single vial that meets EU quality standards. Compared with formulations containing fewer components, it may provide a more comprehensive amino acid profile, but clinical choice depends on patient-specific needs, compatibility with other nutrients, and institutional protocols.

Olimel N5e should be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. Before use, inspect the solution for particulate matter or discoloration, and allow it to reach room temperature if required for infusion. Follow aseptic techniques during preparation.

The solution is administered intravenously, typically via a peripheral or central venous catheter, as part of a parenteral nutrition regimen. Infusion rates are set by the prescribing clinician and may be adjusted based on the patient’s metabolic tolerance, fluid balance, and concurrent therapies. Compatibility with other IV solutions should be confirmed before mixing.

Serious adverse reactions include anaphylactic or severe hypersensitivity responses, metabolic acidosis, hyperammonemia, and significant electrolyte disturbances. Clinicians should monitor vital signs, laboratory parameters, and the infusion site during and after administration, and be prepared to intervene promptly if severe reactions occur.

Patients with known hypersensitivity to any of the listed amino acids, those with inborn errors of metabolism affecting these amino acids (e.g., phenylketonuria), and individuals with severe renal or hepatic impairment without appropriate dose adjustment should avoid Olimel N5e unless a specialist determines it is safe.